skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Consortium to develop the medical uses of NMR imaging, NMR spectroscopy, and positron emission tomography. Final technical report

Abstract

The goal of this work is to, perform clinically relevant studies using a new whole-body 4.1 T NMR imaging spectrometer. Initially we will develop and approach for the assessment of the severity of skeletal muscle involvement in ischemic peripheral vascular disease.

Authors:
Publication Date:
Research Org.:
Alabama Univ., Birmingham, AL (United States)
Sponsoring Org.:
USDOE Office of Energy Research, Washington, DC (United States)
OSTI Identifier:
607522
Report Number(s):
DOE/ER/61386-T1
ON: DE98005340; IN: DOE/ER/GI--386-1; TRN: 98:002084
DOE Contract Number:  
FG05-92ER61386
Resource Type:
Technical Report
Resource Relation:
Other Information: PBD: [1998]
Country of Publication:
United States
Language:
English
Subject:
55 BIOLOGY AND MEDICINE, BASIC STUDIES; NMR IMAGING; SPECTROSCOPY; MUSCLES; VASCULAR DISEASES; DIAGNOSTIC TECHNIQUES; ISCHEMIA; LACTIC ACID; CARBON 13; HYDROGEN 1; GLYCOGEN

Citation Formats

Pohost, G M. Consortium to develop the medical uses of NMR imaging, NMR spectroscopy, and positron emission tomography. Final technical report. United States: N. p., 1998. Web. doi:10.2172/607522.
Pohost, G M. Consortium to develop the medical uses of NMR imaging, NMR spectroscopy, and positron emission tomography. Final technical report. United States. https://doi.org/10.2172/607522
Pohost, G M. 1998. "Consortium to develop the medical uses of NMR imaging, NMR spectroscopy, and positron emission tomography. Final technical report". United States. https://doi.org/10.2172/607522. https://www.osti.gov/servlets/purl/607522.
@article{osti_607522,
title = {Consortium to develop the medical uses of NMR imaging, NMR spectroscopy, and positron emission tomography. Final technical report},
author = {Pohost, G M},
abstractNote = {The goal of this work is to, perform clinically relevant studies using a new whole-body 4.1 T NMR imaging spectrometer. Initially we will develop and approach for the assessment of the severity of skeletal muscle involvement in ischemic peripheral vascular disease.},
doi = {10.2172/607522},
url = {https://www.osti.gov/biblio/607522}, journal = {},
number = ,
volume = ,
place = {United States},
year = {Mon Jun 01 00:00:00 EDT 1998},
month = {Mon Jun 01 00:00:00 EDT 1998}
}